{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:20:25Z","timestamp":1790335225474,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.clinthera.2008.02.006","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T15:11:31Z","timestamp":1208445091000},"page":"249-259","source":"Crossref","is-referenced-by-count":21,"title":["Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Victor L.","family":"Serebruany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex I.","family":"Malinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex N.","family":"Pokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.02.006_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"Suppl 22","key":"10.1016\/j.clinthera.2008.02.006_bib2","first-page":"S691","article-title":"Update on aspirin in treatment and prevention of cardiovascular disease","volume":"8","author":"Hennekens","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2008.02.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinthera.2008.02.006_bib4","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial [published correction appears in Lancet. 2007;369:274]","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.02.006_bib5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.02.006_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.02.006_bib7","first-page":"S4","article-title":"Standards of medical care in diabetes-2006","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2008.02.006_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMsb020987","article-title":"Transient ischemic attack-proposal for a new definition","volume":"347","author":"Albers","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.02.006_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09537100400020161","article-title":"Can platelet aggregometry be standardized?","volume":"16","author":"Breddin","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.clinthera.2008.02.006_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clinthera.2008.02.006_bib11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.CIR.99.5.620","article-title":"Rapid platelet-function assay: An automated and quantitative cartridge-based method","volume":"99","author":"Smith","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.02.006_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.1993.tb38785.x","article-title":"Flow cytometric measurement of platelet function and reticulated platelets","volume":"677","author":"Ault","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2008.02.006_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0037-1614464","article-title":"The relations of major platelet receptor expression during myocardial infarction. Monitoring efficacy of GPIIb\/IIIa inhibitors by measuring P-selectin?","volume":"81","author":"Serebruany","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2008.02.006_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0014-2999(81)90362-9","article-title":"Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man","volume":"70","author":"Lorenz","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.114","article-title":"Magnitude and time course of platelet inhibition with Aggrenox and aspirin in patients after ischemic stroke: The AGgrenox versus Aspirin Therapy Evaluation (AGATE) Trial","volume":"499","author":"Serebruany","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.STR.0000064326.65899.AC","article-title":"Platelet function under aspirin, clopidogrel, and both after ischemic stroke: A case-crossover study","volume":"34","author":"Grau","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2008.02.006_bib17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.STR.0000181081.09262.e1","article-title":"Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke","volume":"36","author":"Serebruany","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2008.02.006_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bjp.0704248","article-title":"Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro","volume":"134","author":"Zhao","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH04-09-0559","article-title":"Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke","volume":"93","author":"Zhao","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2008.02.006_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09537100500235966","article-title":"Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke","volume":"17","author":"Zhao","year":"2006","journal-title":"Platelets"},{"key":"10.1016\/j.clinthera.2008.02.006_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.thromres.2004.03.002","article-title":"Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy","volume":"113","author":"Serebruany","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2008.02.006_bib22","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2008.02.006_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00129784-200404020-00003","article-title":"Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus","volume":"4","author":"Colwell","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.clinthera.2008.02.006_bib24","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1161\/01.CIR.0000018123.02672.C7","article-title":"Impact of different platelet glycoprotein Ilb\/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up","volume":"105","author":"Roffi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.02.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2004.08.054","article-title":"Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)","volume":"95","author":"Stuckey","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0735-1097(00)01041-X","article-title":"Absolute quantitation of coronary steal induced by intravenous dipyridamole","volume":"37","author":"Akinboboye","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.02.006_bib27","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/WNL.57.suppl_2.S20","article-title":"Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells","volume":"57","author":"Eisert","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.02.006_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0891-5849(94)E0123-Z","article-title":"A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole","volume":"18","author":"Iuliano","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinthera.2008.02.006_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00609581","article-title":"Enhanced prostacyclin production by dipyridamole in man","volume":"21","author":"Neri Serneri","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(91)90629-5","article-title":"Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide","volume":"199","author":"Bult","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.02.006_bib31","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.57.suppl_2.S8","article-title":"Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction","volume":"57","author":"Muller","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.02.006_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0735-1097(94)90752-8","article-title":"Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: Implications in the treatment of restenosis after angioplasty","volume":"23","author":"Singh","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.02.006_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","volume":"23","author":"Diener","year":"2007","journal-title":"Cerebrovasc Dis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T12:12:01Z","timestamp":1557490321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0149291808000891"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.02.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}